No Data
No Data
North China Pharmaceutical Secures EU GMP Certification
Here's Why North China Pharmaceutical Company.Ltd (SHSE:600812) Has A Meaningful Debt Burden
North China Pharmaceutical Subsidiary Passes GMP Compliance Inspection
North China Pharmaceutical (600812.SH) subsidiary passed the Pharmaceutical GMP compliance inspection.
North China Pharmaceutical (600812.SH) announced that its wholly-owned subsidiary, North China Pharmaceutical Group Shentai Pharmaceutical Co., Ltd...
Improved Revenues Required Before North China Pharmaceutical Company.Ltd (SHSE:600812) Stock's 28% Jump Looks Justified
North China Pharmaceutical Company.Ltd (SHSE:600812) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Five Years, but the Stock Ascends 4.2% This Past Week